Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood test may predict ICU death risk

NCT ID NCT07493759

Knowledge-focused Sponsor: Ataturk University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study examined whether a blood test called the Systemic Immune-Inflammation Index (SII) can predict the risk of death in critically ill patients in the intensive care unit (ICU). Researchers looked back at the records of 570 adults admitted to the ICU. They found that higher SII levels at admission were linked to a higher chance of dying during the ICU stay. The goal is to see if this simple, cheap test can help doctors quickly identify high-risk patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

570 people

The number who actually took part.

Started

Dec 2025

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients aged 18 years or older admitted to the reanimation intensive care unit for infectious or non-infectious critical illness, with available admission laboratory data

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 years or older * Admission to the reanimation intensive care unit * Availability of admission complete blood count and biochemical laboratory data * Admission due to infectious or non-infectious critical illness Exclusion Criteria: * Pregnancy * Hematologic malignancy * Active chemotherapy * Chronic immunosuppression * Pulse steroid therapy * Known thrombocytopenia (platelet count \<50×10\^9/L) * Massive bleeding or massive transfusion within the first 24 hours of ICU admission * Incomplete clinical or laboratory data

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Critical illness are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Critical Illness infectious disease with sepsis Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Critical illness Sepsis

Contacts and locations

Locations

  • Atatürk University Faculty of Medicine Hospital

    Erzurum, 25100, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.